An oral formulation and other forms of delivery are big and important puddles for RACE to jump. Will eventually make the benefits of the drug more readily and hence widely available to patients and make it more practical for the indications outside of cancer. It will potentially expand the opportunities for partnership and potentially be of big interest to suitors.
- Forums
- ASX - By Stock
- RAC
- Ann: Preclinical & Clinical Programs Update
Ann: Preclinical & Clinical Programs Update, page-21
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.86 |
Change
-0.080(4.12%) |
Mkt cap ! $315.1M |
Open | High | Low | Value | Volume |
$1.95 | $1.95 | $1.84 | $367.9K | 195.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 244 | $1.86 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.87 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 244 | 1.860 |
1 | 3965 | 1.855 |
2 | 1900 | 1.850 |
3 | 6900 | 1.845 |
2 | 60374 | 1.840 |
Price($) | Vol. | No. |
---|---|---|
1.870 | 2000 | 1 |
1.875 | 250 | 1 |
1.880 | 2865 | 2 |
1.885 | 2800 | 2 |
1.890 | 2235 | 1 |
Last trade - 12.33pm 15/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |